These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11232196)

  • 1. Mechanisms of cholestasis.
    Kullak-Ublick GA; Meier PJ
    Clin Liver Dis; 2000 May; 4(2):357-85. PubMed ID: 11232196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary transport.
    Kullak-Ublick GA; Beuers U; Paumgartner G
    J Hepatol; 2000; 32(1 Suppl):3-18. PubMed ID: 10728790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The descending pathophysiology model of cholestatic liver disease].
    Cai XB; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):321-324. PubMed ID: 31177654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestasis and cholestatic syndromes.
    Pratt DS
    Curr Opin Gastroenterol; 2005 May; 21(3):270-4. PubMed ID: 15818146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
    Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
    Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular bile salt transport: lessons from cholestasis.
    Trauner M; Fickert P; Stauber RE
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New molecular features of cholestatic diseases of the liver].
    Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
    Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
    Marrone J; Danielli M; Gaspari CI; Marinelli RA
    IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
    Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
    Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular transporters and cholestasis.
    Pauli-Magnus C; Meier PJ
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations.
    Trauner M
    Yale J Biol Med; 1997; 70(4):365-78. PubMed ID: 9626757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salt transporters: molecular characterization, function, and regulation.
    Trauner M; Boyer JL
    Physiol Rev; 2003 Apr; 83(2):633-71. PubMed ID: 12663868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic liver (dys)function during sepsis and other critical illnesses.
    Jenniskens M; Langouche L; Vanwijngaerden YM; Mesotten D; Van den Berghe G
    Intensive Care Med; 2016 Jan; 42(1):16-27. PubMed ID: 26392257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bile salt export pump: molecular properties, function and regulation.
    Arrese M; Ananthanarayanan M
    Pflugers Arch; 2004 Nov; 449(2):123-31. PubMed ID: 15578267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestasis: pathophysiology and pathobiochemistry.
    Krell H; Enderle GJ
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():11-5. PubMed ID: 7483688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
    Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
    Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
    Accatino L; Figueroa C; Pizarro M; Solís N
    J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is cholestasis in 1985?
    Erlinger S
    J Hepatol; 1985; 1(6):687-93. PubMed ID: 3902958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile Acids in Cholestasis and its Treatment.
    Arab JP; Cabrera D; Arrese M
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.